Patient centricity

Warning letters increase as DSI rejigs operations

Warning letters increase as DSI rejigs operations

By Nick Taylor

FDA warning letters to clinical trial investigators have increased by 50 per cent in 2009 as a consequence of improved processes at DSI, a spokesperson told Outsourcing-Pharma.

Follow us

Products

View more

Webinars